Emet Surgical

Emet Surgical is pioneering AI-driven surgical intelligence with its ESP platform, designed to act as a 'surgical co-pilot' by providing real-time visual guidance and anomaly detection during procedures. The technology, built on over 20 person-years of licensed university research, is a software-only solution that integrates with existing OR equipment without requiring new hardware, contrast agents, or extensive surgeon training. The company is currently raising a $3M seed round, planning clinical validation studies, and targeting FDA 510(k) clearance by Q2 2027, initially focusing on incidental cancer detection and endometriosis identification.

ESP (Enhanced Surgical Precision): An AI-powered computer vision software platform for real-time anomaly detection and visual overlay guidance in minimally invasive surgery. It integrates with existing laparoscopic/robotic systems without new hardware or contrast agents.

Emet Surgical competes in the rapidly evolving surgical AI space against large medtech companies (e.g., Intuitive Surgical, Medtronic, Stryker) integrating AI into their platforms, as well as startups focused on computer-assisted surgery. Its key differentiation is the pure-software, no-hardware, no-dye approach aimed at seamless integration and low barrier to adoption.